These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 13678837

  • 1. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M, Willinger B, Egner R, Ecker G, Kuchler K.
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [Abstract] [Full Text] [Related]

  • 2. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, Niimi M, Tanabe K, Monk BC, Cannon RD.
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [Abstract] [Full Text] [Related]

  • 3. Enhanced susceptibility to antifungal oligopeptides in yeast strains overexpressing ABC multidrug efflux pumps.
    Wakiec R, Gabriel I, Prasad R, Becker JM, Payne JW, Milewski S.
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4057-63. PubMed ID: 18794383
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR, Keniya MV, Ivnitski-Steele I, Monk BC, Lamping E, Sklar LA, Cannon RD.
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K, Niimi M, Niimi K, Holmes AR, Yates JE, Decottignies A, Monk BC, Goffeau A, Cannon RD.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 12. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M, Niimi K, Takano Y, Holmes AR, Fischer FJ, Uehara Y, Cannon RD.
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [Abstract] [Full Text] [Related]

  • 13. Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.
    Gauthier C, Weber S, Alarco AM, Alqawi O, Daoud R, Georges E, Raymond M.
    Antimicrob Agents Chemother; 2003 May; 47(5):1543-54. PubMed ID: 12709320
    [Abstract] [Full Text] [Related]

  • 14. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK, Thota CK, Verma SD, Sharma J, Rawal MK, Ravikumar B, Sen S, Chauhan N, Lynn AM, Chauhan VS, Prasad R.
    J Biol Chem; 2013 Jun 07; 288(23):16775-16787. PubMed ID: 23592791
    [Abstract] [Full Text] [Related]

  • 15. FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops.
    Tanabe K, Bonus M, Tomiyama S, Miyoshi K, Nagi M, Niimi K, Chindamporn A, Gohlke H, Schmitt L, Cannon RD, Niimi M, Lamping E.
    Antimicrob Agents Chemother; 2019 Jan 07; 63(1):. PubMed ID: 30348662
    [Abstract] [Full Text] [Related]

  • 16. Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function.
    Tanabe K, Lamping E, Nagi M, Okawada A, Holmes AR, Miyazaki Y, Cannon RD, Monk BC, Niimi M.
    Mol Microbiol; 2011 Oct 07; 82(2):416-33. PubMed ID: 21895791
    [Abstract] [Full Text] [Related]

  • 17. Learning the ABC of oral fungal drug resistance.
    Cannon RD, Holmes AR.
    Mol Oral Microbiol; 2015 Dec 07; 30(6):425-37. PubMed ID: 26042641
    [Abstract] [Full Text] [Related]

  • 18. Voriconazole and multidrug resistance in Candida albicans.
    Wakieć R, Prasad R, Morschhäuser J, Barchiesi F, Borowski E, Milewski S.
    Mycoses; 2007 Mar 07; 50(2):109-15. PubMed ID: 17305773
    [Abstract] [Full Text] [Related]

  • 19. An actin depolymerizing agent 19,20-epoxycytochalasin Q of Xylaria sp. BCC 1067 enhanced antifungal action of azole drugs through ROS-mediated cell death in yeast.
    Somboon P, Soontorngun N.
    Microbiol Res; 2021 Feb 07; 243():126646. PubMed ID: 33227681
    [Abstract] [Full Text] [Related]

  • 20. Yeast ATP-binding cassette transporters conferring multidrug resistance.
    Prasad R, Goffeau A.
    Annu Rev Microbiol; 2012 Feb 07; 66():39-63. PubMed ID: 22703054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.